journal article·2020-12-11

Neuropeptide Substance P Released from a Nonswellable Laponite-Based Hydrogel Enhances Wound Healing in a Tissue-Engineered Skin In Vitro

Thiéry De Serres-Bérard, Tiago B. Becher, Carolyne B. Braga, Catia Ornelas, François Berthod

ACS Applied Polymer Materials· Volume 2· Issue 12
Publisher page

Abstract

Chronic wounds associated with diabetes remain a worldwide clinical challenge. Substance P (SP), which is an 11-amino acid neuropeptide secreted in the skin mainly by sensory neurons, has been reported to promote diabetic wound healing. However, like many bioactive peptides, the low stability of SP in the protease-rich wound environment limits its therapeutic topical application. To provide protection to SP and enable its sustained release in the wound, we have prepared an injectable Laponite nanodiscs-based hydrogel loaded with SP and evaluated its wound healing ability in a human tissue-engineered skin model. This hydrogel is nonswellable, self-standing, biodegradable and biocompatible, and the simple fabrication process with mild conditions have enabled the encapsulation of controlled concentrations of SP. Rheological experiments further showed the self-healing and shear-thinning behavior of this system. Histological analysis showed that the application of hydrogel did not alter the aspect or the differentiation of nearby epidermis, confirming its biocompatibility. Remarkably, one-time application experiments demonstrated that the hydrogel HSP2 containing SP at 10–5 M induced 98% wound closure within 16 days, whereas the control sample did not achieve full reepithelialization. This result indicated that SP was successfully released from the hydrogel and was available for keratinocytes to stimulate the reepithelialization process. Thus, the obtained data suggested that our SP-loaded hydrogel promoted wound healing, making it a potential formulation to be used as chronic wound dressing.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Wound Healing and Treatments · Laser Applications in Dentistry and Medicine · Silk-based biomaterials and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

LOEX, CHU de Quebec-Laval University Research Center, Quebec City G1J 1Z4, Canada

Institute of Chemistry, University of Campinas -UNICAMP, Campinas, SP 13083-861, Brazil

Department of Surgery, Faculty of Medicine, Laval University, Quebec City G1V 0A6, Canada

Funding

Canadian Institutes of Health Research · Fonds de Recherche du Québec - Santé · Conselho Nacional de Desenvolvimento Científico e Tecnológico · Fundação de Amparo à Pesquisa do Estado de São Paulo · Coordenação de Aperfeiçoamento de Pessoal de Nível Superior · Fondation du CHU de Québec

References (53)

Show source-provided references
1. 10.1111/j.1524-475X.2009.00543.x10.1111/j.1524-475X.2009.00543.x ↗
2. 10.1242/dmm.01678210.1242/dmm.016782 ↗
3. 10.2174/138920101866617051909533910.2174/1389201018666170519095339 ↗
4. 10.1001/jama.293.2.21710.1001/jama.293.2.217 ↗
5. 10.2119/2006-00054.Brem10.2119/2006-00054.Brem ↗
6. 10.1016/S0002-9440(10)63754-610.1016/S0002-9440(10)63754-6 ↗
7. 10.1016/j.jss.2007.02.04410.1016/j.jss.2007.02.044 ↗
8. 10.1016/j.actbio.2017.11.04510.1016/j.actbio.2017.11.045 ↗
9. 10.1002/14651858.CD008548.pub210.1002/14651858.CD008548.pub2 ↗
10. 10.1016/j.addr.2018.07.01910.1016/j.addr.2018.07.019 ↗
11. 10.3892/mmr.2014.192110.3892/mmr.2014.1921 ↗
12. 10.1002/jcp.2914210.1002/jcp.29142 ↗
13. 10.1016/j.actbio.2018.10.01110.1016/j.actbio.2018.10.011 ↗
14. 10.1016/j.ajpath.2015.02.01110.1016/j.ajpath.2015.02.011 ↗
15. 10.1124/mol.115.10101410.1124/mol.115.101014 ↗
16. 10.1016/j.biomaterials.2010.07.07910.1016/j.biomaterials.2010.07.079 ↗
17. 10.1089/ten.tea.2013.053510.1089/ten.tea.2013.0535 ↗
18. 10.1177/15353702052300040710.1177/153537020523000407 ↗
19. 10.1007/s12325-014-0140-x10.1007/s12325-014-0140-x ↗
20. 10.1089/ten.tea.2016.051710.1089/ten.tea.2016.0517 ↗
21. 10.1016/j.jdermsci.2017.12.00910.1016/j.jdermsci.2017.12.009 ↗
22. 10.1046/j.1523-1747.2002.01865.x10.1046/j.1523-1747.2002.01865.x ↗
23. 10.3791/5257610.3791/52576 ↗
24. 10.1016/j.vascn.2017.10.00310.1016/j.vascn.2017.10.003 ↗
25. 10.1007/s12325-017-0478-y10.1007/s12325-017-0478-y ↗
26. 10.1039/C4CS00332B10.1039/C4CS00332B ↗
27. 10.1016/j.eurpolymj.2017.12.04610.1016/j.eurpolymj.2017.12.046 ↗
28. 10.1016/j.eurpolymj.2020.10960910.1016/j.eurpolymj.2020.109609 ↗
29. 10.1021/am800045610.1021/am8000456 ↗
30. 10.1039/c3tb20940g10.1039/c3tb20940g ↗
31. 10.1021/nn503719n10.1021/nn503719n ↗
32. 10.1016/j.eurpolymj.2014.11.02410.1016/j.eurpolymj.2014.11.024 ↗
33. 10.1021/acs.chemrev.5b0029910.1021/acs.chemrev.5b00299 ↗
34. 10.1002/adfm.20150148910.1002/adfm.201501489 ↗
35. 10.1021/acsami.0c0318710.1021/acsami.0c03187 ↗
36. 10.1021/acsami.0c0775310.1021/acsami.0c07753 ↗
37. 10.1021/acsami.7b0939510.1021/acsami.7b09395 ↗
38. 10.1021/acsami.7b0480110.1021/acsami.7b04801 ↗
39. 10.1021/acsami.7b0285010.1021/acsami.7b02850 ↗
40. 10.1002/term.244510.1002/term.2445 ↗
41. 10.3390/molecules2309221510.3390/molecules23092215 ↗
42. 10.1021/acsami.8b2163810.1021/acsami.8b21638 ↗
43. 10.1021/acsabm.0c0066610.1021/acsabm.0c00666 ↗
44. 10.1021/acsami.9b1718010.1021/acsami.9b17180 ↗
45. 10.1002/slct.20170029210.1002/slct.201700292 ↗
46. 10.1039/C8SM01965G10.1039/C8SM01965G ↗
47. 10.1007/978-1-59745-060-7_1510.1007/978-1-59745-060-7_15 ↗
48. 10.1002/jcp.2294310.1002/jcp.22943 ↗
49. 10.3390/pharmaceutics904005610.3390/pharmaceutics9040056 ↗
50. 10.3390/ijms2018445310.3390/ijms20184453 ↗
51. 10.1021/acsami.8b0614910.1021/acsami.8b06149 ↗
52. 10.4049/jimmunol.160175110.4049/jimmunol.1601751 ↗
53. 10.1002/psc.309310.1002/psc.3093 ↗